Suppr超能文献

前列腺癌患者的治疗决策偏好应在研究和临床常规中记录:四项调查研究中 7169 例患者的汇总分析。

The Treatment Decision-making Preferences of Patients with Prostate Cancer Should Be Recorded in Research and Clinical Routine: a Pooled Analysis of Four Survey Studies with 7169 Patients.

机构信息

Division of Psychooncology, Department of General Internal Medicine and Psychosomatic, University Hospital of Heidelberg, INF 410, 69120, Heidelberg, Germany.

Department of Urology, Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.

出版信息

J Cancer Educ. 2022 Jun;37(3):675-682. doi: 10.1007/s13187-020-01867-2. Epub 2020 Sep 17.

Abstract

Different patients want to take different roles in the treatment decision-making process; these roles can be classified as passive, collaborative, and active. The aim of this study was to investigate the correlation between decision-making preferences among patients with prostate cancer and personal, disease-related, and structural factors. In four survey studies, we asked 7169 prostate cancer patients about their decision-making preferences using the Control Preferences Scale (CPS) and collected clinical, psychological, and quality-of-life measures. Most patients (62.2%) preferred collaborative decision-making, while 2322 (32.4%) preferred an active role, and only 391 (5.5%) preferred a passive role. Age (p < 0.001), data collection mode (p < 0.001), peer-to-peer support (p = 0.018), treatment status (p < 0.001), performed or planned radical prostatectomy (p < 0.001), metastatic disease (p = 0.001), and quality of life (p < 0.001) showed significant associations with patients' preferred decision-making roles. Oncologic risk group, anxiety, and depression were not significant in the model. In particular, younger prostate cancer patients with higher quality of life completing an online survey want to play a more active role in treatment decision-making. Before treatment has started, patients tend to prefer collaborative decision-making. Few prostate cancer patients in Germany prefer a passive role. These patients are mostly older patients, patients with a metastatic disease, and patients who have opted for prostatectomy. Whether this finding reflects a generational effect or a tendency by age group and disease phase should be investigated. Further research is also needed to describe the causalities of these relationships. The CPS offers valuable information for personal counselling and should be applied in clinical routine. In a large group of patients with prostate cancer, we found that there is a strong desire for joint decision-making with the physician before the actual treatment. Especially younger men, men with active online behaviour, and men with a high quality of life want to be actively involved in therapy decision-making processes.

摘要

不同的患者希望在治疗决策过程中扮演不同的角色;这些角色可以分为被动、协作和主动。本研究旨在调查前列腺癌患者的决策偏好与个人、疾病相关和结构因素之间的相关性。在四项调查研究中,我们使用控制偏好量表(CPS)询问了 7169 名前列腺癌患者的决策偏好,并收集了临床、心理和生活质量测量数据。大多数患者(62.2%)更喜欢协作式决策,而 2322 名(32.4%)更喜欢主动角色,只有 391 名(5.5%)更喜欢被动角色。年龄(p<0.001)、数据收集方式(p<0.001)、同伴支持(p=0.018)、治疗状况(p<0.001)、已行或计划行根治性前列腺切除术(p<0.001)、转移性疾病(p=0.001)和生活质量(p<0.001)与患者的偏好决策角色显著相关。肿瘤风险组、焦虑和抑郁在模型中无显著意义。特别是,生活质量较高、年龄较小、完成在线调查的前列腺癌患者更希望在治疗决策中发挥更积极的作用。在开始治疗之前,患者倾向于选择协作式决策。德国很少有前列腺癌患者选择被动角色。这些患者大多是年龄较大的患者、患有转移性疾病的患者以及选择前列腺切除术的患者。这种发现是反映代际效应还是年龄组和疾病阶段的倾向,应进一步调查。还需要进一步研究来描述这些关系的因果关系。CPS 为个人咨询提供了有价值的信息,应在临床常规中应用。在一大群前列腺癌患者中,我们发现患者在实际治疗前强烈希望与医生共同做出决策。特别是年轻男性、积极上网的男性和生活质量较高的男性,希望积极参与治疗决策过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c1a9/9205804/702b6679aba3/13187_2020_1867_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验